Epigenetic Therapy Targets Th1/Th17 Polarization to Reversing Immune Evasion and Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation in Non-APL AML Patients
Yang, Xi, Zheng, Hong, Dai, Jingying, Li, Chenglong, Zhang, Rong, WANG, Xiaodong, Wang, Chunsen, Huang, Xiaobing
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia
Yang, Xi, Li, Chenglong, Zhang, Rong, Zheng, Hong, Wei, Qing, Wang, Chunsen, Dai, Jingying, Huang, Xiaobing, Tang, Ningning
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
This Is a Title in Chidamide, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO
Yang, Xi, Huang, Xiaobing, Zheng, Hong, Li, Chenglong, Dai, Jingying, Zhang, Rong, Wang, Xiaodong, Wang, Chunsen
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Lenalidomide overcomes the immunosuppression of regulatory CD8 + CD28 - T-cells
Neuber, Brigitte, Dai, Jingying, Waraich, Wjahat A, Awwad, Mohamed H S, Engelhardt, Melanie, Schmitt, Michael, Medenhoff, Sergej, Witzens-Harig, Mathias, Ho, Anthony D, Goldschmidt, Hartmut, Hundemer, Michael
Published in Oncotarget (17.11.2017)
Published in Oncotarget (17.11.2017)
Get full text
Journal Article
Information recommendation method and device, equipment and storage medium
LIU BIN, LU XIAYAN, JI XIANGYU, DAI JINGYING, XIONG HONGYU, LIU ZHE, MENG LINGTONG, LIU ZHEN, WEI QIFAN
Year of Publication 25.05.2021
Get full text
Year of Publication 25.05.2021
Patent